163 related articles for article (PubMed ID: 11514694)
1. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations.
Dentener MA; Creutzberg EC; Schols AM; Mantovani A; van't Veer C; Buurman WA; Wouters EF
Thorax; 2001 Sep; 56(9):721-6. PubMed ID: 11514694
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
Schols AM; Buurman WA; Staal van den Brekel AJ; Dentener MA; Wouters EF
Thorax; 1996 Aug; 51(8):819-24. PubMed ID: 8795671
[TBL] [Abstract][Full Text] [Related]
3. Role of TNF-α, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease.
Zeng M; Wen Y; Liu LY; Wang H; Guan KP; Huang X
Respiration; 2009; 78(4):399-403. PubMed ID: 19339767
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
5. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U
Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824
[TBL] [Abstract][Full Text] [Related]
6. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
Vernooy JH; Küçükaycan M; Jacobs JA; Chavannes NH; Buurman WA; Dentener MA; Wouters EF
Am J Respir Crit Care Med; 2002 Nov; 166(9):1218-24. PubMed ID: 12403691
[TBL] [Abstract][Full Text] [Related]
7. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease.
Takabatake N; Nakamura H; Abe S; Inoue S; Hino T; Saito H; Yuki H; Kato S; Tomoike H
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1179-84. PubMed ID: 10764309
[TBL] [Abstract][Full Text] [Related]
8. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.
Bhowmik A; Seemungal TA; Sapsford RJ; Wedzicha JA
Thorax; 2000 Feb; 55(2):114-20. PubMed ID: 10639527
[TBL] [Abstract][Full Text] [Related]
9. [Concentration of interleukin-18, interleukin-1beta, soluble receptor for interleukin-1 (sIL-1RII) and C-reactive protein in patients with neuroborreliosis].
Pietruczuk A; Swierzbińska R; Pietruczuk M; Kondrusik M; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T
Neurol Neurochir Pol; 2005; 39(1):33-9. PubMed ID: 15735988
[TBL] [Abstract][Full Text] [Related]
10. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease.
Creutzberg EC; Wouters EF; Vanderhoven-Augustin IM; Dentener MA; Schols AM
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1239-45. PubMed ID: 11029324
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.
Partsch G; Wagner E; Leeb BF; Dunky A; Steiner G; Smolen JS
J Rheumatol; 1998 Jan; 25(1):105-10. PubMed ID: 9458212
[TBL] [Abstract][Full Text] [Related]
12. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease.
Roland M; Bhowmik A; Sapsford RJ; Seemungal TA; Jeffries DJ; Warner TD; Wedzicha JA
Thorax; 2001 Jan; 56(1):30-5. PubMed ID: 11120901
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study.
Eagan TM; Ueland T; Wagner PD; Hardie JA; Mollnes TE; Damås JK; Aukrust P; Bakke PS
Eur Respir J; 2010 Mar; 35(3):540-8. PubMed ID: 19643942
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease.
Takabatake N; Nakamura H; Inoue S; Terashita K; Yuki H; Kato S; Yasumura S; Tomoike H
Respir Med; 2000 Dec; 94(12):1215-20. PubMed ID: 11192958
[TBL] [Abstract][Full Text] [Related]
16. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
17. Increased systemic inflammation is a risk factor for COPD exacerbations.
Groenewegen KH; Postma DS; Hop WC; Wielders PL; Schlösser NJ; Wouters EF;
Chest; 2008 Feb; 133(2):350-7. PubMed ID: 18198263
[TBL] [Abstract][Full Text] [Related]
18. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?
Rahman I; Swarska E; Henry M; Stolk J; MacNee W
Thorax; 2000 Mar; 55(3):189-93. PubMed ID: 10679536
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils.
Oudijk EJ; Nijhuis EH; Zwank MD; van de Graaf EA; Mager HJ; Coffer PJ; Lammers JW; Koenderman L
Thorax; 2005 Jul; 60(7):538-44. PubMed ID: 15994259
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
